论文部分内容阅读
目的 :探讨介入治疗缺血性脑血管疾病的中长期预后及安全性应用。方法 :选取我院符合血管内支架植入治疗标准的缺血性脑血管疾病患者256例,随机分成介入治疗组120例和对照组136例。介入治疗组进行血管内支架成形术治疗,对照组进行常规药物治疗。对两组患者治疗前后的病情用神经功能缺损评分(NIHSS评分)标准进行评定,并随访治疗后6个月和12个月的缺血性脑血管事件发生率。将两组结果进行统计学分析。结果 :介入治疗组在治疗后6个月、12个月的NIHSS评分与治疗前相比差异均有统计学意义;与对照组相比,介入治疗组在治疗后6个月和12个月的缺血性脑血管事件发生率差异均有统计学意义。结论 :血管内支架成形术是治疗缺血性脑血管病的安全有效方法,中长期疗效及预后优于单纯药物治疗,提高了患者的生活质量和生存率。
Objective: To investigate the long-term prognosis and safety of interventional therapy for ischemic cerebrovascular disease. Methods: A total of 256 patients with ischemic cerebrovascular disease who met the criteria of endovascular stent implantation in our hospital were randomly divided into interventional treatment group (120 cases) and control group (136 cases). Interventional treatment group for endovascular stenting, the control group for conventional drug treatment. Two groups of patients before and after treatment with neurological deficit score (NIHSS score) criteria for assessment and follow-up treatment of 6 months and 12 months after the occurrence of ischemic cerebrovascular events. The two groups of results were statistically analyzed. Results: There was significant difference in NIHSS score between the intervention group and the control group at 6 and 12 months after treatment. Compared with the control group, the NIHSS scores at 6 and 12 months after treatment The incidence of ischemic cerebrovascular events were statistically significant. Conclusion: Endovascular stenting is a safe and effective method for the treatment of ischemic cerebrovascular disease. The long-term curative effect and prognosis are superior to those of simple drug therapy and improve the quality of life and survival rate of patients.